Proteomic analysis of peripheral blood mononuclear cells in first episode psychosis – Protein and peptide-centered approaches to elucidate potential diagnostic biomarkers
Journal of Proteomics · 2024
DOI: 10.1016/j.jprot.2024.105296 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2024. Verfasst von Catia Santa und 13 weiteren Autor:innen. Beteiligte Einrichtung: CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Centre for Innovative Biomedicine and Biotechnology, U…. Hauptthemen laut MEDLINE: Psychotic Disorders, Biomarkers, Proteomics, Leukocytes, Mononuclear. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Fundação para a Ciência e a Tecnologia, Rede Nacional de Espectrometria de Massa, European Social Fund Plus.
Abstract (Originalsprache)
Diagnosing patients suffering from psychotic disorders is far from being achieved with molecular support, despite all the efforts to study these disorders from different perspectives. Characterizing the proteome of easily obtainable blood specimens, such as the peripheral blood mononuclear cells (PBMCs), has particular interest in biomarker discovery and generating pathophysiological knowledge. This approach has been explored in psychiatry, and while generating valuable information, it has not translated into meaningful biomarker discovery. In this project, we report the proof-of-concept of a methodology that aims to explore further information obtained with classical proteomics approaches that is easily overlooked. PBMC samples from first-episode psychosis and control subjects were subjected to a SWATH-MS approach, and the classical protein relative quantification was performed, where 389 proteins were found to be important to distinguish the two groups. Individual analysis of the quantified peptides was also performed, highlighting peptides of unchanged proteins that were significantly altered. With the combination of protein- and peptide-centered proteomics approaches, it is possible to highlight that information about proteoforms, namely regulation at the peptide level possibly due to post-translational modifications, is routinely overlooked and that its diagnostic potential should be further explored. SIGNIFICANCE: Our exploratory findings highlight the potential of MS-based proteomics strategies, combining protein- and peptide-centered approaches, to aid clinical decision-making in first-episode psychosis, helping to establish early biomarkers for schizophrenia and other psychotic disorders. Particularly, the less popular peptide-centered approach allows the identification/measurement of overlooked modulated peptides that may have potential biomarker characteristics. The application in parallel of protein- and peptide-centered strategies is transversal to research of other diseases, potentially allowing a more comprehensive characterization of the metabolic/pathophysiological alterations related to a specific disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal.
- Faculty of Medicine of the University of Coimbra, University of Coimbra, Portugal; Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, Portugal; CIBIT - Coimbra Institute for Biomedical Imaging and Tran…
- CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine of the University of Coimbra, University of Coimbra, Portugal; Psychiatry Department, Centro Hosp…
- Psychiatry Department, Centro Hospitalar e Universitário de Coimbra, Portugal.
- CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; Faculty of Medicine of the Un…
- CNC-Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal; CIBB - Centre for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal; III Institute for Interdiscip…
Förderung
- Fundação para a Ciência e a Tecnologia
- Rede Nacional de Espectrometria de Massa
- European Social Fund Plus
- Programa Operacional Temático Factores de Competitividade
- European Regional Development Fund
Zitieren
APA
Santa, C., Rodrigues, J. E., Martinho, A., Mendes, V. M., Madeira, N., Coroa, M., Santos, V., Morais, S., Bajouco, M., Costa, H., Anjo, S. I., Baldeiras, I., Macedo, A., & Manadas, B. (2024). Proteomic analysis of peripheral blood mononuclear cells in first episode psychosis – Protein and peptide-centered approaches to elucidate potential diagnostic biomarkers. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2024.105296
Vancouver
Santa C, Rodrigues JE, Martinho A, Mendes VM, Madeira N, Coroa M, et al. Proteomic analysis of peripheral blood mononuclear cells in first episode psychosis – Protein and peptide-centered approaches to elucidate potential diagnostic biomarkers. Journal of Proteomics. 2024. doi:10.1016/j.jprot.2024.105296
BibTeX
@article{Santa2024,
author = {Santa, Catia and Rodrigues, João E and Martinho, Ana and Mendes, Vera M and Madeira, Nuno and Coroa, Manuel and Santos, Vítor and Morais, Sofia and Bajouco, Miguel and Costa, Hélder and Anjo, Sandra I and Baldeiras, Inês and Macedo, Antonio and Manadas, Bruno},
title = {Proteomic analysis of peripheral blood mononuclear cells in first episode psychosis – Protein and peptide-centered approaches to elucidate potential diagnostic biomarkers},
journal = {Journal of Proteomics},
year = {2024},
doi = {10.1016/j.jprot.2024.105296}
}
EUVIMED